Koyfin Home > Directory > Health Care > Biogen Inc > EBITDA

Biogen Inc EBITDA Chart (BIIB)

Biogen Inc annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Biogen Inc EBITDA for the quarter ending September 09, 2020 was $1,134m a -61.93% decrease of -702m year over year
  • Biogen Inc EBITDA for the last 12 months ending September 09, 2020 was $6,963m a -11.16% decrease of -777m year over year
  • Biogen Inc Annual EBITDA for 2019 was $7,740m a 9.37% increase of 725m from 2018
  • Biogen Inc Annual EBITDA for 2018 was $7,015m a 5.80% increase of 407m from 2017
  • Biogen Inc Annual EBITDA for 2017 was $6,608m a 3.96% increase of 262m from 2016
Other Income Statement Metrics:
  • Biogen Inc Net Income for the quarter ending December 12, 2018 was $947m a -23.88% decrease of -226m year over year
  • Biogen Inc Total Revenue for the quarter ending December 12, 2018 was $3,526m a 11.21% increase of 395m year over year
View Chart On Koyfin

Quarterly BIIB EBITDA Data

09/2020$1,134m
06/2020$2,111m
03/2020$2,010m
12/2019$1,836m
09/2019$2,070m
06/2019$2,078m
03/2019$1,751m
12/2018$1,852m
09/2018$1,990m
06/2018$1,463m

Annual BIIB EBITDA Data

2019$7,740m
2018$7,015m
2017$6,608m
2016$6,346m
2015$5,615m
2014$4,605m
2013$3,022m
2012$2,204m
2011$2,123m
2010$1,931m